(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Fascioliasis D005211 3 associated lipids
Fatigue D005221 10 associated lipids
Fatty Liver D005234 48 associated lipids
Fetal Macrosomia D005320 3 associated lipids
Forearm Injuries D005543 1 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Gastroenteritis D005759 4 associated lipids
Glioma D005910 112 associated lipids
Glycogen Storage Disease Type I D005953 4 associated lipids
Glycogen Storage Disease D006008 4 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Biswas A et al. Production of poly-3-hydroxyalkanoic acids by a moderately halophilic bacterium, Halomonas marina HMA 103 isolated from solar saltern of Orissa, India. 2009 Acta Microbiol Immunol Hung pmid:19621765
Subekti I Post-prandial hyperglycemia in type 2 diabetes mellitus, diabetic cornea neuropathy and beta hydroxyl butyrate in diabetic ketoacidosis. 2004 Jul-Sep Acta Med Indones pmid:15568228
Gustaviani R et al. The influence of calorie restriction during the Ramadan fast on serum fructosamine and the formation of beta hydroxybutirate in type 2 diabetes mellitus patients. 2004 Jul-Sep Acta Med Indones pmid:15557682
Wijaya IP et al. Beta-hydroxybutirate levels as a determinant for the success of diabetic ketoacidosis management. 2004 Apr-Jun Acta Med Indones pmid:15673940
Styrud J and Eriksson UJ Effects of D-glucose and beta-hydroxybutyric acid on the in vitro development of (pre)chondrocytes from embryos of normal and diabetic rats. 1990 Acta Endocrinol. pmid:2333734
Mooradian AD Metabolic fuel and amino acid transport into the brain in experimental hypothyroidism. 1990 Acta Endocrinol. pmid:2316307
Larsen S et al. The effect of insulin withdrawal on intermediary metabolism in patients with diabetes secondary to chronic pancreatitis. 1991 Acta Endocrinol. pmid:2028708
Hermansen K et al. Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study. 1987 Acta Endocrinol. pmid:3551432
Home PD et al. Impaired subcutaneous absorption of insulin in 'brittle' diabetics. 1982 Acta Endocrinol. pmid:6756010
De Pergola G et al. D-(-)-beta-hydroxybutyrate inhibits catecholamine-stimulated lipolysis and decreases beta-adrenoceptors' affinity in human fat cells but not in lymphomonocytes. 1990 Acta Endocrinol. pmid:2159203